Skip to main content
Account
Fig. 6: Dysregulation of KLF2 signalling in ECFCs from IPAH patients. | Nature Communications

Fig. 6: Dysregulation of KLF2 signalling in ECFCs from IPAH patients.

From: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

Fig. 6: Dysregulation of KLF2 signalling in ECFCs from IPAH patients.

a KLF2 mRNA, b miR-181 and c miR-324, d ETS-1 and e Notch4 expression in ECFCs from healthy volunteers (n = 14) and IPAH patients (n = 12). f, g Proliferation (EdU incorporation) and h angiogenesis (matrigel tube formation) in ECFCs from healthy individuals and IPAH patients, transfected with control miRNA, control siRNA, miR-181 and miR-324 or Notch4 and ETS-1 siRNA, as indicated. Representative corresponding images of tube formation in fluorescently labelled live ECFCs are shown underneath the graph. In g EdU-incorporating nuclei are pink. In g bar = 20 µm and in h bar = 100 µm; *P < 0.05, **P < 0.001, comparison with corresponding controls; #P < 0.05, ##P < 0.01, comparison between controls and miR-181 and miR-324- or ETS-1 and Notch4-treated IPAH ECFCs. Bars are means ± s.e.m. In a–en = 12–14, unpaired t-test and in f, hn = 4–8, one-way ANOVA with Tukey post-test. All n numbers are biologically independent samples. Source data are provided in Source Data file.

Back to article page